Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2012-08-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Questionnaire will be self-administrated to Dermatology outpatients.
Testing will be performed at the practice of 2 Dermatologists experts in rosacea who will evaluate subjects' answers and propose fine-tuning of the questionnaire content, if needed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rosacea patients
Questionnaire testing on routine dermatologist patient population
Questionnaire testing
Questionnaire testing on rosacea and non-rosacea dermatology outpatients
non-rosacea patients
Questionnaire testing on routine dermatologist patient population
Questionnaire testing
Questionnaire testing on rosacea and non-rosacea dermatology outpatients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire testing
Questionnaire testing on rosacea and non-rosacea dermatology outpatients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject visiting one of the study dermatology practices for daily care/routine dermatology consultation.
* Subject have to read and sign the approved Informed Consent form prior to any participation in the study,
* Subject willing and capable of cooperating to the extend and degree required by the protocol
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabien AUDIBERT, Bsc
Role: STUDY_DIRECTOR
Galderma R&D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jerry TAN
Windsor, Ontario, Canada
Mats BERG
Eskilstuna, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD.03.SPR.29105
Identifier Type: -
Identifier Source: org_study_id